Adjuvant therapy may improve overall survival in high-risk periampullary adenocarcinomas patients - A match-pair analysis from a multi-institutional cohort study (The MIPPAP study).
Ramaswamy A, Chaudhari V, Srinivas S, Bhargava P, Kannan S, Agarwal A, Seshadri RA, Talwar V, Goel S, Goel V, Singh S, Kayal S, Rebala P, Rao GV, Prajapati B, Parikh D, Kothari J, Kadamapuzha JM, Ramesh H, Kapoor D, Chaudhary A, Gupta A, Sekar A, Misra S, Vishnoi JR, Soni S, Varshney VK, Bairwa SK, Ghosh J, Lavingia V, Bhandare M, Shrikhande SV, Ostwal V.
Ramaswamy A, et al. Among authors: vishnoi jr.
HPB (Oxford). 2024 Oct;26(10):1261-1269. doi: 10.1016/j.hpb.2024.06.010. Epub 2024 Jul 2.
HPB (Oxford). 2024.
PMID: 39019675